Company profile
Liom Health AG
Spiden aspires to become the benchmark platform for longevity and preventative medicine by providing real-time biomarker and drug analysis to empower clinicians, patients, as well as healthy individuals in making more informed and timely decisions and increase the safety and efficacy of medical treatments. It has developed the world's first data generation platform to perform spectroscopic measurements of a wide range of biomarkers and drugs in blood.
Source: startup.ch
The new Swiss Venture Capital Report was published on 26 January. It analyses 304 financing rounds closed in 2020 and includes further article such as an interview with Michael Hengartner, President of the ETH Board, and a list of Swiss "soonicorns". 
